S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:HUGE

FSD Pharma (HUGE) Stock Price, News & Analysis

$0.72
+0.01 (+1.42%)
(As of 03/28/2024 ET)
Today's Range
$0.69
$0.72
50-Day Range
$0.67
$1.06
52-Week Range
$0.65
$2.10
Volume
32,653 shs
Average Volume
133,740 shs
Market Capitalization
$28.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HUGE stock logo

About FSD Pharma Stock (NASDAQ:HUGE)

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

HUGE Stock Price History

HUGE Stock News Headlines

FSD Pharma (HUGE) Scheduled to Post Earnings on Friday
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
HUGE Mar 2024 1.000 call
FSD Pharma Inc.: FSD Pharma Announces US ATM Offering
FSD Pharma Announces US ATM Offering
FSD Pharma Inc Class B (HUGE)
Pitch Deck Teardown: PhageLab’s $11M Series A deck
FSD Pharma Inc. Announces Closing of Private Placement
See More Headlines
Receive HUGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
3/28/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:HUGE
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

Net Income
$-23,610,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.79 per share

Miscellaneous

Free Float
36,002,000
Market Cap
$28.17 million
Optionable
Optionable
Beta
0.61
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Zeeshan Saeed (Age 54)
    Founder, CEO, President & Executive Co-Chairman
    Comp: $375.98k
  • Mr. Anthony John Durkacz (Age 48)
    Founder & Executive Co-Chairman
    Comp: $375.98k
  • Mr. Nathan Coyle CPA (Age 43)
    Chief Financial Officer
    Comp: $191.89k
  • Mr. Donal Carroll CPA (Age 47)
    Chief Operating Officer
    Comp: $375.98k
  • Dr. Lakshmi P. Kotra BPHARM (Age 53)
    Ph.D., CEO of Lucid & Director
    Comp: $331.51k
  • Dr. Andrzej Chruscinski M.D.
    Ph.D., Vice President of Clinical & Scientific Affairs of Lucid
  • Mr. Kevin Cassidy
    Vice President of Quality-Lucid
  • Ms. Maryann Adesso
    Corporate Secretary
  • Randell Mack
    President of FSD BioSciences

HUGE Stock Analysis - Frequently Asked Questions

How have HUGE shares performed in 2024?

FSD Pharma's stock was trading at $0.9198 at the beginning of the year. Since then, HUGE shares have decreased by 22.2% and is now trading at $0.7156.
View the best growth stocks for 2024 here
.

When is FSD Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our HUGE earnings forecast
.

How were FSD Pharma's earnings last quarter?

FSD Pharma Inc. (NASDAQ:HUGE) issued its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.11.

What other stocks do shareholders of FSD Pharma own?
Who are FSD Pharma's major shareholders?

FSD Pharma's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include AdvisorShares Investments LLC (0.69%), Scotia Capital Inc. (0.16%) and Citadel Advisors LLC (0.00%).

How do I buy shares of FSD Pharma?

Shares of HUGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HUGE) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners